BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10629138)

  • 1. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
    Faber J; Kantarjian H; Roberts MW; Keating M; Freireich E; Albitar M
    Arch Pathol Lab Med; 2000 Jan; 124(1):92-7. PubMed ID: 10629138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.
    Yasmeen S; Rajkumar A; Grossman H; Szallasi A
    Pediatr Dev Pathol; 2017; 20(6):463-468. PubMed ID: 29187045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia.
    Liu L; McGavran L; Lovell MA; Wei Q; Jamieson BA; Williams SA; Dirks NN; Danielson MS; Dubie LM; Liang X
    Am J Clin Pathol; 2004 Jun; 121(6):810-5. PubMed ID: 15198352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
    Umiel T; Pattengale P; Weinberg K
    Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
    Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
    Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
    Valmary S; Danjoux M; Delsol G; Brousset P
    Ann Pathol; 2005 Feb; 25(1):25-32. PubMed ID: 15981929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic heterogeneity of TDT+ cells in the blood and bone marrow: implications for surveillance of residual leukemia.
    Smith RG; Kitchens RL
    Blood; 1989 Jul; 74(1):312-9. PubMed ID: 2473798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
    Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
    J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal deoxynucleotidyl transferase expression can precede T cell receptor beta chain and gamma chain rearrangement in T cell acute lymphoblastic leukemia.
    Greenberg JM; Kersey JH
    Blood; 1987 Jan; 69(1):356-60. PubMed ID: 3491642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal deoxynucleotidyl transferase (TdT)-negative T-cell lymphoblastic lymphoma with loss of the T-cell lineage-specific marker CD3 at relapse: a rare entity with an aggressive outcome.
    Hassan M; Abdullah HMA; Wahid A; Qamar MA
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29884716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells.
    Gore SD; Kastan MB; Civin CI
    Blood; 1991 Apr; 77(8):1681-90. PubMed ID: 2015396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
    Tang YM
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
    Gore SD; Kastan MB; Goodman SN; Civin CI
    J Immunol Methods; 1990 Sep; 132(2):275-86. PubMed ID: 1698878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
    van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
    Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotyping of acute lymphoblastic leukemia using immunohistochemistry in bone marrow biopsy specimens.
    Al Gwaiz LA; Bassioni W
    Histol Histopathol; 2008 Oct; 23(10):1223-8. PubMed ID: 18712674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.